Related references
Note: Only part of the references are listed.Lipidome alterations in human prefrontal cortex during development, aging, and cognitive disorders
Qianhui Yu et al.
MOLECULAR PSYCHIATRY (2020)
The re-emerging pathophysiological role of the cystathionine-β-synthase - hydrogen sulfide system in Down syndrome
Csaba Szabo
FEBS JOURNAL (2020)
HLA Class II Allele Analyses Implicate Common Genetic Components in Type 1 and Non-Insulin-Treated Type 2 Diabetes
Thomas Jacobi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133
Yahu A. Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Palmitate Is Increased in the Cerebrospinal Fluid of Humans with Obesity and Induces Memory Impairment in Mice via Pro-inflammatory TNF-α
Helen M. Melo et al.
CELL REPORTS (2020)
A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons
Sergio Espeso-Gil et al.
GENOME MEDICINE (2020)
The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson?s Disease
Lingyu Zhang et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Targeting Mitochondrial Network Architecture in Down Syndrome and Aging
Nunzia Mollo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Antonella Tramutola et al.
NEUROBIOLOGY OF DISEASE (2020)
ApoE and cerebral insulin: Trafficking, receptors, and resistance
Elizabeth M. Rhea et al.
NEUROBIOLOGY OF DISEASE (2020)
Inflammation and fatness in adolescents with and without Down syndrome: UP & DOWN study
A. Gutierrez-Hervas et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2020)
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease
Eugenio Barone et al.
MOLECULAR NEUROBIOLOGY (2019)
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity
Flavia Agata Cimini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Insulin Resistance and Oxidative Stress in the Brain: What's New?
Mateusz Maciejczyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Dementia in Down syndrome: unique insights for Alzheimer disease research
Ira T. Lott et al.
NATURE REVIEWS NEUROLOGY (2019)
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
Fabio Di Domenico et al.
REDOX BIOLOGY (2019)
Trisomy 21 Is a Cause of Permanent Neonatal Diabetes That Is Autoimmune but Not HLA Associated
Matthew B. Johnson et al.
DIABETES (2019)
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
Nidhi Sharma et al.
NEUROBIOLOGY OF DISEASE (2019)
mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy
Matteo Bordi et al.
CELL DEATH & DISEASE (2019)
Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease
Thomas J. Gross et al.
DEVELOPMENTAL NEUROBIOLOGY (2019)
Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome
Theodora Panagaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Activation of the ISR mediates the behavioral and neurophysiological abnormalities in Down syndrome
Ping Jun Zhu et al.
SCIENCE (2019)
Suppressing Aneuploidy-Associated Phenotypes Improves the Fitness of Trisomy 21 Cells
Sunyoung Hwang et al.
CELL REPORTS (2019)
Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer
Etna Abad et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Down syndrome: Neurobiological alterations and therapeutic targets
Rosa Anna Vacca et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Insulin action in the brain regulates mitochondrial stress responses and reduces diet-induced weight gain
Kristina Wardelmann et al.
MOLECULAR METABOLISM (2019)
A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis
Dong Soo Seo et al.
MOLECULAR METABOLISM (2019)
Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance
W. A. Banks et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
Biochemical and cellular properties of insulin receptor signalling
Rebecca A. Haeusler et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: Implications for Alzheimer disease
Francesca Triani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism
Eugenio Barone et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Increased levels of inflammatory plasma markers and obesity risk in a mouse model of Down syndrome
M. Fructuoso et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Mitochondria as pharmacological targets in Down syndrome
Daniela Valenti et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease
Daniel J. Colacurcio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions
Jung Hyun Lee et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models
Chiara Lanzillotta et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
Andre F. Batista et al.
JOURNAL OF PATHOLOGY (2018)
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
Antonella Izzo et al.
MOLECULAR MEDICINE (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
Lactate in the brain: from metabolic end-product to signalling molecule
Pierre J. Magistretti et al.
NATURE REVIEWS NEUROSCIENCE (2018)
Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models
Christian Holscher
NEUROPHARMACOLOGY (2018)
Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism
Maria Caracausi et al.
SCIENTIFIC REPORTS (2018)
Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis
Elizabeth Head et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells
Maria Chiara Pelleri et al.
FRONTIERS IN GENETICS (2018)
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Antonella Tramutola et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Chromosomal contacts connect loci associated with autism, BMI and head circumference phenotypes
M. N. Loviglio et al.
MOLECULAR PSYCHIATRY (2017)
Down syndrome and the complexity of genome dosage imbalance
Stylianos E. Antonarakis
NATURE REVIEWS GENETICS (2017)
mTORC1 inhibition with rapamycin exacerbates adipose tissue inflammation in obese mice and dissociates macrophage phenotype from function
Vivian A. Paschoal et al.
IMMUNOBIOLOGY (2017)
Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial
Suzanne Craft et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Amyloid- oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons
Gisele S. Seixas da Silva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Concentrations of leptin, adiponectin and other metabolic parameters in non-obese children with Down syndrome
Nikhil Tenneti et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2017)
Brain insulin resistance impairs hippocampal synaptic plasticity and memory by increasing GluA1 palmitoylation through FoxO3a
Matteo Spinelli et al.
NATURE COMMUNICATIONS (2017)
Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis
Yan Zhang et al.
ONCOTARGET (2017)
p70 S6 Kinase and Tau in Alzheimer's Disease
Jin-Jing Pei et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Thyroid dysfunction in patients with Down syndrome: Results from a multi-institutional registry study
Jenifer Lavigne et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration
Saurabh Kumar Jha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics
Fabio Di Domenico et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Marian Valko et al.
ARCHIVES OF TOXICOLOGY (2016)
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
Elizabeth Head et al.
CURRENT ALZHEIMER RESEARCH (2016)
Morbidity and medication in a large population of individuals with Down syndrome compared to the general population
Myriam Alexander et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2016)
Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's Syndrome
Antonella Tramutola et al.
NEURODEGENERATIVE DISEASES (2016)
An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation
M. Florencia Iulita et al.
ALZHEIMERS & DEMENTIA (2016)
Adipose extracellular matrix remodelling in obesity and insulin resistance
De Lin et al.
BIOCHEMICAL PHARMACOLOGY (2016)
The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model
Daniela Valenti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?
Matthias Blueher
CLINICAL SCIENCE (2016)
DYRK1A: A Promising Drug Target for Islet Transplant-Based Diabetes Therapies
Bengt-Frederik Belgardt et al.
DIABETES (2016)
Lipid profiles in a large cohort of Italian children with Down syndrome
Paola Sabrina Buonuomo et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2016)
Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation
Tihomir Miralem et al.
FASEB JOURNAL (2016)
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm
Eugenio Barone et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
The contribution of the citrate pathway to oxidative stress in Down syndrome
Paolo Convertini et al.
IMMUNOLOGY (2016)
Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
Molly Stanley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice
Zhenjiang Liu et al.
JOURNAL OF LIPID RESEARCH (2016)
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
Rafael de la Torre et al.
LANCET NEUROLOGY (2016)
Mouse models of Down syndrome: gene content and consequences
Meenal Gupta et al.
MAMMALIAN GENOME (2016)
Impaired fasting glucose is associated with increased regional cerebral amyloid
Jill K. Morris et al.
NEUROBIOLOGY OF AGING (2016)
A Syntenic Cross Species Aneuploidy Genetic Screen Links RCAN1 Expression to β-Cell Mitochondrial Dysfunction in Type 2 Diabetes
Heshan Peiris et al.
PLOS GENETICS (2016)
The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health
Henrieta Skovierova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Down syndrome and Alzheimer's disease: Common pathways, common goals
Dean Hartley et al.
ALZHEIMERS & DEMENTIA (2015)
Chromosome 21-derived hsa-miR-155-5p regulates mitochondrial biogenesis by targeting Mitochondrial Transcription Factor A (TFAM)
Adolfo Quinones-Lombrana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
DYRK1A BAC Transgenic Mouse: A New Model of Thyroid Dysgenesis in Down Syndrome
Dulanjalee Kariyawasam et al.
ENDOCRINOLOGY (2015)
Galectin-3 in autoimmunity and autoimmune diseases
Felipe L. de Oliveira et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Inhibition of BACE2 counteracts hIAPP-induced insulin secretory defects in pancreatic β-cells
Gema Alcarraz-Vizan et al.
FASEB JOURNAL (2015)
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD
Antonella Tramutola et al.
JOURNAL OF NEUROCHEMISTRY (2015)
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
Peng Wang et al.
NATURE MEDICINE (2015)
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Frances K. Wiseman et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease
Donna M. Wilcock et al.
NEUROBIOLOGY OF AGING (2015)
The role of type 2 diabetes in neurodegeneration
Giuseppe Verdile et al.
NEUROBIOLOGY OF DISEASE (2015)
Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Aβ42 Concentrations in Down Syndrome Young Adults
Laura Del Hoyo et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Phosphorylation and Inactivation of Glycogen Synthase Kinase 3β (GSK3β) by Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A)
Woo-Joo Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The Brain Response to Peripheral Insulin Declines with Age: A Contribution of the Blood-Brain Barrier?
Tina Sartorius et al.
PLOS ONE (2015)
Risk of Major Cardiovascular Events in People with Down Syndrome
Christopher G. Sobey et al.
PLOS ONE (2015)
Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia (vol 44, pg 897, 2015)
Amy Claxton et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Bach1 Overexpression in Down Syndrome Correlates with the Alteration of the HO-1/BVR-A System: Insights for Transition to Alzheimer's Disease
Fabio Di Domenico et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Associations of ghrelin with eating behaviors, stress, metabolic factors, and telomere length among overweight and obese women: Preliminary evidence of attenuated ghrelin effects in obesity?
Julia Buss et al.
APPETITE (2014)
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain
D. Allan Butterfield et al.
BIOCHEMICAL JOURNAL (2014)
Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain
Marzia Perluigi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
D. Allan Butterfield et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance
Latif Rachdi et al.
CELL CYCLE (2014)
Elevated levels of extracellular, heat-shock protein 72 (eHSP72) are positively correlated with insulin resistance in vivo and cause pancreatic β-cell dysfunction and death in vitro
Mauricio Krause et al.
CLINICAL SCIENCE (2014)
Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass
Latif Rachdi et al.
DIABETOLOGIA (2014)
Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease
Fabio Di Domenico et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Autoimmune Predisposition in Down Syndrome May Result from a Partial Central Tolerance Failure due to Insufficient Intrathymic Expression of AIRE and Peripheral Antigens
Mireia Gimenez-Barcons et al.
JOURNAL OF IMMUNOLOGY (2014)
Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates
Leticia Forny-Germano et al.
JOURNAL OF NEUROSCIENCE (2014)
Hyperhomocysteinemia: Related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues
Vito Lacobazzi et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Domains of genome-wide gene expression dysregulation in Down's syndrome
Audrey Letourneau et al.
NATURE (2014)
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology
Miranda E. Orr et al.
NEUROBIOLOGY OF AGING (2014)
Impaired glycemia increases disease progression in mild cognitive impairment
Jill K. Morris et al.
NEUROBIOLOGY OF AGING (2014)
Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: An overview of Down syndrome, autism, Fragile X and Rett syndrome
Daniela Valenti et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
THYROID HORMONE REGULATION OF METABOLISM
Rashmi Mullur et al.
PHYSIOLOGICAL REVIEWS (2014)
Obesity and overweight in intellectual and non- intellectually disabled children
E. Slevin et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2014)
Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: Redox proteomics analysis of human brain
Fabio Di Domenico et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer's β-Amyloid Oligomers in Mice and Monkeys
Mychael V. Lourenco et al.
CELL METABOLISM (2013)
Adaptive Downregulation of Mitochondrial Function in Down Syndrome
Pablo Helguera et al.
CELL METABOLISM (2013)
A major role for RCAN1 in atherosclerosis progression
Nerea Mendez-Barbero et al.
EMBO MOLECULAR MEDICINE (2013)
Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects
Claudia Piccoli et al.
HUMAN MOLECULAR GENETICS (2013)
Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain
Md. Mahiuddin Ahmed et al.
HUMAN MOLECULAR GENETICS (2013)
Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease
Amy Claxton et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Bioelectrical impedance for measuring percentage body fat in young persons with Down syndrome: validation with dual-energy absorptiometry
Sarah J. Loveday et al.
ACTA PAEDIATRICA (2012)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome
Giovanna Cenini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Selective Insulin and Leptin Resistance in Metabolic Disorders
A. Christine Koenner et al.
CELL METABOLISM (2012)
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
K. D. Copps et al.
DIABETOLOGIA (2012)
Increased Expression of the Glucose-Responsive Gene, RCAN1, Causes Hypoinsulinemia, β-Cell Dysfunction, and Diabetes
Heshan Peiris et al.
ENDOCRINOLOGY (2012)
Down Syndrome and Thyroid Function
Evan Graber et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
Rohit Loomba et al.
HEPATOLOGY (2012)
HO-1/BVR-A System Analysis in Plasma from Probable Alzheimer's Disease and Mild Cognitive Impairment Subjects: A Potential Biochemical Marker for the Prediction of the Disease
Fabio Di Domenico et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers
Theresa R. Bomfim et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Konrad Talbot et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical model
Rima Obeid et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Prevalence of Overweight in Dutch Children With Down Syndrome
Helma B. M. van Gameren-Oosterom et al.
PEDIATRICS (2012)
Lipid Profiles of Children With Down Syndrome Compared With Their Siblings
Tahira Adelekan et al.
PEDIATRICS (2012)
Trisomy 21 and early brain development
Tarik F. Haydar et al.
TRENDS IN NEUROSCIENCES (2012)
Leptin, insulin and thyroid hormones in a cohort of Egyptian obese Down syndrome children: a comparative study
Sohier Yahia et al.
BMC ENDOCRINE DISORDERS (2012)
Minibrain/Dyrk1a Regulates Food Intake through the Sir2-FOXO-sNPF/NPY Pathway in Drosophila and Mammals
Seung-Hyun Hong et al.
PLOS GENETICS (2012)
Mitochondrial Dysfunction in Neurodegenerative Diseases
Ashu Johri et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway
Daniela Valenti et al.
BIOCHEMICAL JOURNAL (2011)
Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment
Eugenio Barone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass
Daria Esterhazy et al.
CELL METABOLISM (2011)
Inflammation Is Necessary for Long-Term but Not Short-Term High-Fat Diet Induced Insulin Resistance
Yun Sok Lee et al.
DIABETES (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Oxidative and Nitrosative Modifications of Biliverdin Reductase-A in the Brain of Subjects with Alzheimer's Disease and Amnestic Mild Cognitive Impairment
Eugenio Barone et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Naturally Secreted Amyloid-β Increases Mammalian Target of Rapamycin (mTOR) Activity via a PRAS40-mediated Mechanism
Antonella Caccamo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Fighting neurodegeneration with rapamycin: mechanistic insights
Jordi Bove et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Behavioral Characterization of a Mouse Model Overexpressing DSCR1/RCAN1
Mara Dierssen et al.
PLOS ONE (2011)
Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid
Marzia Perluigi et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
Accuracy of prediction equations to assess percentage of body fat in children and adolescents with Down syndrome compared to air displacement plethysmography
A. Gonzalez-Agueero et al.
RESEARCH IN DEVELOPMENTAL DISABILITIES (2011)
Impairment of F1F0-ATPase, adenine nucleotide translocator and adenylate kinase causes mitochondrial energy deficit in human skin fibroblasts with chromosome 21 trisomy
Daniela Valenti et al.
BIOCHEMICAL JOURNAL (2010)
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS
Antonella Caccamo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
Aileen M. Moloney et al.
NEUROBIOLOGY OF AGING (2010)
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-beta Levels in a Mouse Model of Alzheimer's Disease
Patricia Spilman et al.
PLOS ONE (2010)
Function and regulation of Dyrk1A: towards understanding Down syndrome
Joongkyu Park et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Molecular genetic analysis of Down syndrome
David Patterson
HUMAN GENETICS (2009)
Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
Fernanda G. De Felice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Pharmacology of mTOR Inhibition
David A. Guertin et al.
SCIENCE SIGNALING (2009)
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Wei-Qin Zhao et al.
FASEB JOURNAL (2008)
Leptin levels among prepubertal children with down syndrome compared with their siblings
Sheela N. Magge et al.
JOURNAL OF PEDIATRICS (2008)
Mitochondria in Neuroplasticity and Neurological Disorders
Mark P. Mattson et al.
NEURON (2008)
Mental retardation in Down syndrome: From gene dosage imbalance to molecular and cellular mechanisms
Mohammed Rachidi et al.
NEUROSCIENCE RESEARCH (2007)
Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain
A. Nistor et al.
NEUROBIOLOGY OF AGING (2007)
Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes
Caterina Proto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based study
R Bergholdt et al.
DIABETOLOGIA (2006)
Understanding the basis for Down syndrome phenotypes
Randall J. Roper et al.
PLOS GENETICS (2006)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation
CJ Carlson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Free and bound leptin in prepubertal children with Down's syndrome and different degrees of adiposity
P Magni et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2004)
Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter
NJ Pearce et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome
JT Richtsmeier et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome
X Altafaj et al.
HUMAN MOLECULAR GENETICS (2001)
Homocysteine metabolism in children with Down syndrome: In vitro modulation
M Pogribna et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Obesity and the regulation of energy balance
BM Spiegelman et al.
CELL (2001)